UBS Group’s iShares iBonds Dec 2035 Term Corporate ETF IBCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.95M Buy
192,994
+34,387
+22% +$891K ﹤0.01% 4091
2025
Q4
$4.11M Buy
158,607
+55,742
+54% +$1.45M ﹤0.01% 4223
2025
Q3
$2.68M Buy
102,865
+69,765
+211% +$1.79M ﹤0.01% 4685
2025
Q2
$848K Buy
+33,100
New +$830K ﹤0.01% 5585

Other funds holding IBCA

UBS Group's IBCA Position: Q1 2026 in Review

UBS Group increased its iShares iBonds Dec 2035 Term Corporate ETF (IBCA) stake by 22% in Q1 2026, buying an estimated $891K and bringing the position to 192,994 shares worth $4.95M. The position accounts for ﹤0.01% of the portfolio, ranked #4091.

UBS Group first reported a position in IBCA in Q2 2025 and has held it in 4 quarters since. 78 funds tracked by Wall St. Rank hold IBCA as of Q1 2026.

  • UBS Group held 192,994 shares of iShares iBonds Dec 2035 Term Corporate ETF worth $4.95M as of Q1 2026.
  • UBS Group bought 34,387 iShares iBonds Dec 2035 Term Corporate ETF shares in Q1 2026, an estimated $891K.
  • iShares iBonds Dec 2035 Term Corporate ETF made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #4091 holding.
  • UBS Group first reported a position in iShares iBonds Dec 2035 Term Corporate ETF in Q2 2025 and has held it in 4 quarters since.
  • 78 funds tracked by Wall St. Rank held iShares iBonds Dec 2035 Term Corporate ETF as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.